Table 3 The effect size of risk factors for CRT in children

From: Risk factors and incidence of central venous access device-related thrombosis in hospitalized children: a systematic review and meta-analysis

Categories

Potential risk factors

n

Effect size

Heterogeneity

Analyzed model

odds ratio

95% CI

P-Value

I2 (%)

P-Value

Patient-related risk factors

Sex (Male vs Female)

23

1.03

0.95–1.12

0.43

24

0.15

Fixed

Age: <1 year old

10

1.27

1.00–1.62

0.05

79

<0.00001

Random

Age: >5 year old

2

1.30

0.86–1.96

0.21

0

0.50

Fixed

Age: >13 year old

3

1.57

0.43–5.70

0.50

72

0.03

Random

Age: continuous variable

5

1.01

1.00–1.02

0.21

73

0.005

Random

History of thrombosis

9

2.78

1.90–4.07

<0.00001

0

0.95

Fixed

History of catheterization

3

1.90

1.23–2.92

0.003

28

0.25

Fixed

Thrombophilia

4

2.28

1.32–3.95

0.003

0

0.60

Fixed

Infection

11

1.37

0.91–2.06

0.13

64

0.002

Random

Sepsis

8

1.20

0.62–2.31

0.58

75

0.0002

Random

Cancer

13

1.38

0.97–1.95

0.07

49

0.02

Random

Cardiovascular disease

18

1.01

0.70–1.44

0.97

76

<0.00001

Random

Gastrointestinal diseases

4

2.09

0.95–4.60

0.07

76

0.006

Random

Neurological disease

3

1.05

0.67–1.63

0.84

58

0.09

Random

Autoimmune disease

2

3.82

1.42–10.31

0.008

0

0.38

Fixed

Asphyxia

2

3.70

0.26–51.97

0.33

71

0.06

Random

ECMO

3

1.52

1.32–1.75

<0.00001

0

0.57

Fixed

CVAD-related risk factors

Geographic location of line placement

3

0.27

0.21–0.34

<0.00001

0

1.00

Fixed

Location of insertion 1 (Femoral VS Jugular)

15

1.69

0.98–2.91

0.06

88

<0.00001

Random

Location of insertion 2 (Femoral VS Subclavian)

12

2.68

2.08–3.46

<0.00001

37

0.09

Fixed

Location of insertion 3 (Subclavian VS Jugular)

13

0.81

0.42–1.54

0.51

74

<0.00001

Random

Location of insertion 4 (Femoral VS Upper extremity)

4

4.81

1.08–21.29

0.04

74

0.009

Random

Location of insertion 5 (Jugular VS Upper extremity)

3

2.30

1.18–4.48

0.01

0

0.62

Fixed

Location of insertion 6 (Subclavian VS Upper extremity)

2

0.68

0.32–1.48

0.33

37

0.21

Fixed

Location of insertion 7 (Brachial VS Basilic)

3

0.71

0.47–1.08

0.11

0

0.73

Fixed

Location of insertion 8 (Brachial VS Cephalic)

3

0.89

0.49–1.64

0.72

35

0.21

Fixed

Location of insertion 9 (Cephalic VS Basilic)

4

0.84

0.52–1.36

0.48

0

0.82

Fixed

Location of insertion 10 (Basilic VS Median vein)

2

0.95

0.38–2.36

0.91

0

0.76

Fixed

Location of insertion 11 (Upper extremity VS Lower extremity)

3

0.63

0.12–3.39

0.59

82

0.003

Random

Catheter size (<5 F VS ≥ 5 F)

6

0.68

0.47–1.00

0.05

0

0.53

Fixed

Catheter dysfunction

4

1.74

1.29–2.35

0.0003

0

0.98

Fixed

Side of insertion (right VS left)

15

0.97

0.77–1.22

0.81

46

0.02

Random

Type of catheter 1 (PICC VS tunnedlled CVC)

6

1.34

0.73–2.46

0.34

64

0.02

Random

Type of catheter 2 (PICC VS nontunneled CVC)

6

1.00

0.52–1.93

0.99

91

<0.00001

Random

Type of catheter 3 (PICC VS Tunneled lines)

6

1.81

1.02–3.21

0.04

76

0.0008

Random

Type of catheter 4 (PICC VS TIVAP)

4

2.17

0.84–5.60

0.11

72

0.01

Random

Type of catheter 5 (PICC VS Hemodialysis catheters)

3

1.00

0.84–1.19

1.00

45

0.16

Fixed

Type of catheter 6 (NON-PICC)

5

0.70

0.31–1.56

0.38

82

0.0002

Random

Type of catheter 7 (tunnedlled CVC VS nontunneled CVC)

5

0.62

0.35–1.10

0.10

54

0.07

Random

Type of catheter 8 (TIVAP VS tunnedlled CVC)

4

0.68

0.30–1.54

0.36

58

0.07

Random

Type of catheter 9 (TIVAP VS nontunneled CVC)

3

0.39

0.09–1.64

0.20

65

0.06

Random

Non-optimal tip location

4

2.75

1.36–5.56

0.005

0

0.82

Fixed

Number of lumens (Multiple VS Singer)

10

1.82

1.13–2.93

0.01

87

<0.00001

Random

Number of catheters (Multiple VS Singer)

3

2.97

2.16–4.08

<0.00001

33

0.23

Fixed

Catheter indwelling time

6

1.01

1.00–1.02

0.008

47

0.09

Fixed

CLABSI

9

4.93

3.02–8.05

<0.00001

41

0.10

Fixed

Difficult insertion

7

1.57

0.90–2.73

0.11

67

0.006

Random

Treatment-related risk factors

TPN

14

1.37

1.10–1.71

0.004

26

0.18

Fixed

Surgery

13

0.90

0.62–1.32

0.59

86

<0.00001

Random

Dialysis

4

1.85

1.56–2.19

<0.00001

6

0.36

Fixed

Mechanical ventilation

8

1.50

1.01–2.22

0.04

66

0.005

Random

Mechanical thromboprophylaxis/limb exercises

4

1.27

0.44–3.67

0.65

81

0.001

Random

Tissue plasminogen activator

2

0.32

0.01–14.82

0.56

92

0.0003

Random

Glucocorticoid

2

2.17

1.36–3.48

0.001

0

0.73

Fixed

Vasoactive drugs

7

1.70

1.22–2.37

0.002

37

0.15

Fixed

Hypertonic liquid

3

3.42

0.76–15.46

0.11

55

0.11

Random

Blood products

7

1.36

0.91–2.03

0.14

0

0.57

Fixed

Cardiac catheterization

2

3.15

1.27–7.83

0.01

88

0.004

Random

Length of hospital admission

2

1.51

0.54–4.22

0.43

73

0.05

Random

  1. CRT central venous access device-related thrombosis, CI confidence interval, I2 tested for heterogeneity, ECMO extracorporeal membrane oxygenation, PICC peripherally inserted central catheter, CVC central venous catheter, TIVAP totally implantable venous access port, CLABSI central line-associated bloodstream infection, TPN total parenteral nutrition.